Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Buy buy buy … shake the tree.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1127)
•••
Comment by GrahamBon Sep 28, 2021 10:53pm
248 Views
Post# 33935297

RE:RE:RE:RE:RE:RE:RE:RE:Buy buy buy … shake the tree.

RE:RE:RE:RE:RE:RE:RE:RE:Buy buy buy … shake the tree.
Terrysmith wrote: Honestly I don't see a buyout anytime soon ,ppl are dream if they think it's going to happen next week or month. I like the story , company and there Tech but I personally think GA is holding this company back IMO ( I have my reasons) so for those reason im going to watch on the sidelines for now. ... but bra you're hilarious your comments kill me on the board sometimes. You have a point too 


Ha Ha
Good to keep it real isn't it.

Nothing Like being free.

yes I agree

A buyout soon is a dream, one that needs a good dose of people spinning tales of china,patents, 4D, and other such aspirations....

All the while the share offerings keep happening and that Lou's sucking sound you hear is-like Eduardo in nsocial network-your shares getting sucked into a large, and growing dilute pool,

while you wait for china,patents, 4D, buyouts .....

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities